Cellebrite Di Stock Performance
| CLBT Stock | USD 14.17 0.58 4.27% |
The firm shows a Beta (market volatility) of 0.0889, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cellebrite's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cellebrite is expected to be smaller as well. At this point, Cellebrite DI has a negative expected return of -0.1%. Please make sure to confirm Cellebrite's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Cellebrite DI performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cellebrite DI has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Cellebrite is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return 4.27 | Five Day Return (4.45) | Year To Date Return (20.57) | Ten Year Return 46.69 | All Time Return 46.69 |
1 | Cellebrite Assessing Valuation After Strong Updated Earnings Guidance and Growth Outlook | 11/19/2025 |
2 | Norwood Investment Partners Opens New 4.3 Million Cellebrite Position | 12/09/2025 |
3 | Growth Review Is Cellebrite DI Ltd stock a safe haven asset - GDP Growth Low Drawdown Investment Strategies - moha.gov.vn | 12/29/2025 |
4 | Cellebrite DI Ltd.s Shareholders Might Be Looking For Exit | 01/13/2026 |
5 | Cellebrite DI Ltd. Receives Consensus Rating of Moderate Buy from Brokerages - MarketBeat | 01/16/2026 |
6 | Cellebrite DI Ltd. ABullCase Theory | 02/03/2026 |
7 | Le rapport Cellebrite sur les tendances de lindustrie en 2026 rvle que dans 97 percent des cas les smartphones sont la principale source de preuves numriques da... | 02/05/2026 |
| Begin Period Cash Flow | 189.5 M | |
| Total Cashflows From Investing Activities | -149.5 M |
Cellebrite | Build AI portfolio with Cellebrite Stock |
Cellebrite Relative Risk vs. Return Landscape
If you would invest 1,561 in Cellebrite DI on November 10, 2025 and sell it today you would lose (144.00) from holding Cellebrite DI or give up 9.22% of portfolio value over 90 days. Cellebrite DI is currently does not generate positive expected returns and assumes 3.4896% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Cellebrite, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cellebrite Target Price Odds to finish over Current Price
The tendency of Cellebrite Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 14.17 | 90 days | 14.17 | about 98.0 |
Based on a normal probability distribution, the odds of Cellebrite to move above the current price in 90 days from now is about 98.0 (This Cellebrite DI probability density function shows the probability of Cellebrite Stock to fall within a particular range of prices over 90 days) .
Cellebrite Price Density |
| Price |
Predictive Modules for Cellebrite
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cellebrite DI. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cellebrite Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cellebrite is not an exception. The market had few large corrections towards the Cellebrite's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cellebrite DI, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cellebrite within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.2 | |
β | Beta against Dow Jones | 0.09 | |
σ | Overall volatility | 1.45 | |
Ir | Information ratio | -0.08 |
Cellebrite Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cellebrite for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cellebrite DI can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cellebrite DI generated a negative expected return over the last 90 days | |
| Cellebrite DI has high historical volatility and very poor performance | |
| Cellebrite DI has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 401.2 M. Net Loss for the year was (283.01 M) with profit before overhead, payroll, taxes, and interest of 382.8 M. | |
| About 43.0% of the company shares are held by company insiders | |
| Latest headline from prnewswire.com: Le rapport Cellebrite sur les tendances de lindustrie en 2026 rvle que dans 97 percent des cas les smartphones sont la principale source de preuves numriques dans les enqutes |
Cellebrite Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cellebrite Stock often depends not only on the future outlook of the current and potential Cellebrite's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cellebrite's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 209.5 M | |
| Cash And Short Term Investments | 447.2 M |
Cellebrite Fundamentals Growth
Cellebrite Stock prices reflect investors' perceptions of the future prospects and financial health of Cellebrite, and Cellebrite fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cellebrite Stock performance.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0524 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 2.96 B | ||||
| Shares Outstanding | 244.47 M | ||||
| Price To Earning | 82.18 X | ||||
| Price To Book | 7.74 X | ||||
| Price To Sales | 7.60 X | ||||
| Revenue | 401.2 M | ||||
| Gross Profit | 382.8 M | ||||
| EBITDA | 67.51 M | ||||
| Net Income | (283.01 M) | ||||
| Cash And Equivalents | 142.51 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 10.97 M | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | 1.84 X | ||||
| Cash Flow From Operations | 132.17 M | ||||
| Earnings Per Share | 0.38 X | ||||
| Market Capitalization | 3.46 B | ||||
| Total Asset | 690.57 M | ||||
| Retained Earnings | (164.86 M) | ||||
| Working Capital | 272.09 M | ||||
About Cellebrite Performance
Assessing Cellebrite's fundamental ratios provides investors with valuable insights into Cellebrite's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Cellebrite is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 46.91 | 44.73 | |
| Return On Tangible Assets | (0.50) | (0.48) | |
| Return On Capital Employed | 0.13 | 0.14 | |
| Return On Assets | (0.47) | (0.45) | |
| Return On Equity | (0.97) | (0.92) |
Things to note about Cellebrite DI performance evaluation
Checking the ongoing alerts about Cellebrite for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cellebrite DI help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cellebrite DI generated a negative expected return over the last 90 days | |
| Cellebrite DI has high historical volatility and very poor performance | |
| Cellebrite DI has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 401.2 M. Net Loss for the year was (283.01 M) with profit before overhead, payroll, taxes, and interest of 382.8 M. | |
| About 43.0% of the company shares are held by company insiders | |
| Latest headline from prnewswire.com: Le rapport Cellebrite sur les tendances de lindustrie en 2026 rvle que dans 97 percent des cas les smartphones sont la principale source de preuves numriques dans les enqutes |
- Analyzing Cellebrite's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cellebrite's stock is overvalued or undervalued compared to its peers.
- Examining Cellebrite's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cellebrite's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cellebrite's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cellebrite's stock. These opinions can provide insight into Cellebrite's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.